Search Within

Prathibha Mohan

Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
Groups
  1. GSK Faculty (12)
  2. Sloan Kettering Institute Faculty (12)
  3. Cancer Biology and Genetics Program Faculty (11)
  4. Sloan Kettering Institute Postdocs (10)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (3)
  6. Center for Pancreatic Cancer Research (3)

More Groups

People
  1. Hans Wendel (11)
  2. Agnes Viale (7)
  3. Elisa De Stanchina (7)
  4. Kamini Man Singh (6)
  5. Man Jiang (5)
  6. Viraj Sanghvi (5)

More People

Years
  1. 2022 (2)
  2. 2021 (2)
  3. 2020 (4)
  4. 2019 (2)
  5. 2017 (1)
  6. 2014 (2)
Publications
  1. Cancer Research (4)
  2. Cancers (2)
  3. Cell (1)
  4. European Journal of Cancer (1)
  5. Journal of Experimental Medicine (1)
  6. Molecular Cancer Research (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. American Association for the Advancement of Science (2)
  3. MDPI (2)
  4. Cell Press (1)
  5. Elsevier Inc. (1)
  6. Nature Research (1)

More Publishers

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequent 4EBP1 amplification induces synthetic dependence on FGFR signaling in cancer
    Meeting Abstract

    Singh, K.; Mohan, P.; Sanghvi, V. R.; Ciriello, G.; Lailler, N.; de Stanchina, E.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Frequent 4EBP1 amplification induces synthetic dependence on FGFR signaling in cancer
    Journal Article

    Mohan, P.; Pasion, J.; Ciriello, G.; Lailler, N.; de Stanchina, E.; Viale, A.; van den Berg, A.; Diepstra, A.; Wendel, H. G.; Sanghvi, V. R.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Targeting eIF4A-dependent translation of KRAS signaling molecules
    Journal Article

    Singh, K.; Lin, J.; Lecomte, N.; Mohan, P.; Gokce, A.; Sanghvi, V. R.; Jiang, M.; Grbovic-Huezo, O.; Burčul, A.; Stark, S. G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • NRF2 activation confers resistance to eIF4A inhibitors in cancer therapy
    Journal Article

    Sanghvi, V. R.; Mohan, P.; Singh, K.; Cao, L.; Berishaj, M.; Wolfe, A. L.; Schatz, J. H.; Lailler, N.; de Stanchina, E.; Viale, A.; more...
    Cancers (2021)

    Fulltext@MSK | Save
  • Coordinate translational control of the kras signaling pathway
    Meeting Abstract

    Singh, K.; Lin, J.; Lecomte, N.; Mohan, P.; Leach, S. D.; Ouyang, Z.; Wendel, H. G.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing
    Journal Article

    Parsa, S.; Ortega-Molina, A.; Ying, H. Y.; Jiang, M.; Teater, M.; Wang, J.; Zhao, C.; Reznik, E.; Pasion, J. P.; Kuo, D.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Inhibiting eIF4A in liposarcoma to identify key regulators using ribosome profiling
    Meeting Abstract

    Mohan, P.; Kim, Y. M.
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • KRAS and RAS signaling network is co-regulated and can be therapeutically blocked by targeting eIF4A dependent translation program
    Meeting Abstract

    Singh, K.; Lin, J.; Lecomte, N.; Mohan, P.; Gokce, A.; Sanghvi, V.; Olivera, G. H.; Jiang, M.; Burčul, A.; Stark, S.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • The oncogenic action of NRF2 depends on de-glycation by fructosamine-3-kinase
    Journal Article

    Sanghvi, V. R.; Leibold, J.; Mina, M.; Mohan, P.; Berishaj, M.; Li, Z.; Miele, M. M.; Lailler, N.; Zhao, C.; de Stanchina, E.; more...
    Cell (2019)

    Fulltext@MSK | Save
  • c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma
    Journal Article

    Singh, K.; Lin, J.; Zhong, Y.; Burčul, A.; Mohan, P.; Jiang, M.; Sun, L.; Yong-Gonzalez, V.; Viale, A.; Cross, J. R.; more...
    Journal of Experimental Medicine (2019)

    Fulltext@MSK | Save